Chronic treatment with SGLT-2 inhibitors is associated with ICU admission and disease severity in patients with diabetic ketoacidosis: a propensity score–matched cohort study
Internal and Emergency Medicine · 2025
DOI: 10.1007/s11739-024-03813-2 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Internal and Emergency Medicine, 2025. Verfasst von Fernando Sebastian-Valles und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Universidad Autónoma de Madrid, Hospital Universitario de La Princesa, Instituto de Investigación Sanitari…. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
SGLT-2 inhibitors (SGLT-2i) are linked to a higher risk of diabetic ketoacidosis (DKA). However, it is still unclear whether the severity of SGLT-2i associated DKA is higher. This is a retrospective cohort study with patients admitted for DKA at a tertiary hospital (2013-2024). Patients were matched by propensity score for age, sex, diabetes duration, type, and ischemic heart disease. ICU admission risk and clinical severity were compared between SGLT-2i users and controls. The matched sample included 105 subjects (35 SGLT-2i users, 70 controls). The average age was 63.1 ± 15.4 years, and 40 (38.1%) patients were women. ICU admission was higher in the treatment group (65.7% versus 24.6%, p < 0.001). A conditional logistic regression showed higher risk of ICU admission in the treatment group (odds ratio 12.7, 95% confidence interval 1.9-84.3, p = 0.009) after adjusting for confounding factors. The treatment group exhibited less favorable blood gas results (pH 7.10 ± 0.17 vs 7.18 ± 0.16, p = 0.024) and shorter symptom duration (2 [1-3] vs 3 [2-7] days, p < 0.002). No significant differences were found in diabetes type, ketonemia, creatinine, or DKA precipitating factors. DKA in patients with diabetes treated with SGLT-2i is associated with more severe acidosis with quicker onset, leading to higher risk of ICU admission compared to patients not receiving this treatment. We recommend temporary discontinuation of SGLT-2i during any acute event until resolution, regardless of diabetes type or the patient's glycemic control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Nutrition, Universidad Autónoma de Madrid, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa, Diego de León 62, 28005, Madrid, Spain. fernando.seb…
- Department of Endocrinology and Nutrition, Universidad Autónoma de Madrid, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa, Diego de León 62, 28005, Madrid, Spain.
- Emergency Department, Hospital Universitario de La Princesa, Madrid, Spain.
ORCID-Profile: Fernando Sebastian-Valles
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Sebastian-Valles, F., Tapia-Sanchiz, M. S., Navas-Moreno, V., Lopez-Ruano, M., Martínez-Otero, C., Carrillo-López, E., Sager La Ganga, C., Raposo-López, J. J., Amar, S., González-Castañar, S., Von Wernitz Teleki, A., Del Arco, C., Arranz-Martín, J. A., & Marazuela, M. (2025). Chronic treatment with SGLT-2 inhibitors is associated with ICU admission and disease severity in patients with diabetic ketoacidosis: a propensity score–matched cohort study. Internal and Emergency Medicine. https://doi.org/10.1007/s11739-024-03813-2
Vancouver
Sebastian-Valles F, Tapia-Sanchiz MS, Navas-Moreno V, Lopez-Ruano M, Martínez-Otero C, Carrillo-López E, et al. Chronic treatment with SGLT-2 inhibitors is associated with ICU admission and disease severity in patients with diabetic ketoacidosis: a propensity score–matched cohort study. Internal and Emergency Medicine. 2025. doi:10.1007/s11739-024-03813-2
BibTeX
@article{SebastianValles2025,
author = {Sebastian-Valles, Fernando and Tapia-Sanchiz, Maria Sara and Navas-Moreno, Victor and Lopez-Ruano, Marta and Martínez-Otero, Carmen and Carrillo-López, Elena and Sager La Ganga, Carolina and Raposo-López, Juan José and Amar, Selma and González-Castañar, Sara and Von Wernitz Teleki, Andres and Del Arco, Carmen and Arranz-Martín, Jose Alfonso and Marazuela, Mónica},
title = {Chronic treatment with SGLT-2 inhibitors is associated with ICU admission and disease severity in patients with diabetic ketoacidosis: a propensity score–matched cohort study},
journal = {Internal and Emergency Medicine},
year = {2025},
doi = {10.1007/s11739-024-03813-2}
}
EUVIMED